2nd Quarter - Report

PARKINSON'S ACTION NETWORK for PARKINSON'S ACTION NETWORK

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

H.R. 2595/S.425, "The National Neurological Diseases Surveillance System Act" all sections; "Department of Labor, Health and Human Services, Education and Related Agencies Appropriations," all sections relating to the National Institutes of Health (NIH); "Department of Defense Appropriations," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 1546/S.829, "The Medicare Access to Rehabilitation Services Act of 2011" all sections; H.R. 4132, "The Faster Access to Specialized Treatments Act of 2011" all sections; S. 2113 "The Transforming the Regulatory Environment to Accelerate Access to Treatment of 2011" all sections; S. 3187 "The Food and Drug Administration Safety and Innovation Act" all sections;

LobbyistCovered position, as disclosed
TIMOTHY JOHNSON —
REBECCA W O'CONNOR —
CATHERINE PUGH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 829 (112th), H.R. 2595 (112th), S. 2113 (112th), H.R. 1546 (112th), S. 425 (112th), S. 3187 (112th), H.R. 4132 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.